RecruitingNot ApplicableNCT06898203

Precision Imaging to Evaluate Kaposi Sarcoma

Precision Imaging to Evaluation Kaposi Sarcoma (PRIME-KS)


Sponsor

Washington University School of Medicine

Enrollment

300 participants

Start Date

Apr 10, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

AIMS 2 \& 3: In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called SkinScan3D for people with kaposi sarcoma. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESkinScan3D

A handheld, simple, low-cost, and user-friendly technology that combines liquid lens technology and artificial intelligence (AI).


Locations(2)

Kenya Medical Research Institute

Kisumu, Kenya

Infectious Diseases Institute, Makerere University

Kampala, Uganda

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06898203


Related Trials